← Home
CVS Health 
Healthcare & biotech / Health care and retail pharmacy
Press Releases
| Date | Press release |
|---|---|
| 2025-05-01 06:30:00 | Cvs Health Corporation Reports First Quarter 2025 Results And Updates Full-year 2025 Guidance First quarter financial highlights total revenues increased to $94.6 billion, up 7.0% compared to prior year gaap diluted eps of $1.41 and adjusted eps of $2.25 generated cash flow from operations of $4.6 billion operational highlights cvs health to exit the individual exchange business aetna® introduces new solutions to ease the patient and provider experience cvs caremark® makes formulary update to improve access to glp-1 drugs 2025 full-year guidance revised gaap diluted eps guidance range to $4.23 to $4.43 from $4.58 to $4.83 raised adjusted eps guidance range to $6.00 to $6.20 from $5.75 to $6.00 raised cash flow from operations guidance to approximately $7.0 billion from approximately $6.5 billion ceo commentary \"as we aim to be the most trusted health care company in america, we are driving greater care, value, and service from our integrated, industry-leading businesses. thanks to a resolute focus on customers, our colleagues across cvs health delivered positive results across our health care benefits, health services and pharmacy & consumer wellness segments, as we continue to build a world of better health around the 185 million consumers we are privileged to serve. |
| 2025-04-08 06:30:00 | Cvs Health Announces Chief Financial Officer Transition Plan; Appoints Chief Medical Officer Woonsocket, r.i. , april 8, 2025 /prnewswire/ -- cvs health® (nyse: cvs) today announced two leadership updates. |
| 2025-04-03 09:00:00 | Cvs Health To Hold First Quarter 2025 Earnings Conference Call Woonsocket, r.i. , april 3, 2025 /prnewswire/ -- cvs health® (nyse: cvs) will hold a conference call with analysts and investors on thursday, may 1 st, 2025, at 8:00 a.m. |
| 2025-03-20 11:16:00 | Cvs Health Declares Quarterly Dividend Woonsocket, r.i. , march 20, 2025 /prnewswire/ -- cvs health® (nyse: cvs) has announced that its board of directors has approved a quarterly dividend of sixty-six and one-half cents ($0.665 cents) per share on the common stock of the corporation. |
| 2025-03-14 06:30:00 | Cvs Weight Management™ Program Improves Health Outcomes While Also Lowering Costs Three and a half million members of cvs caremark’s clients now enjoy access to clinical weight loss program with proven results, high satisfaction woonsocket, r.i. , march 14, 2025 /prnewswire/ -- cvs health® (nyse: cvs) released compelling data today from the cvs weight managementtm program in which participants achieved more than 15% weight loss on average, including existing anti-obesity medication users who succeeded in nearly doubling their pre-program weight loss while working with program clinicians on diet and lifestyle.1 before enrolling in the cvs weight management program, 70% of members were using a weight management drug without any lifestyle or nutrition support.1 the initial results demonstrate improved weight loss and high program satisfaction for cvs caremark clients’ plan members trying a lifestyle-first approach and additional clinical effectiveness and cost savings for members receiving clinical support while taking weight management medications like glp-1s. |
© 2024 - 2025 InsightfulValue.com. All rights reserved.
Legal